FDA’s Call on Lilly’s Covid Drug Is Lifting a Partner’s Beaten-Down Stock

FDA’s Call on Lilly’s Covid Drug Is Lifting a Partner’s Beaten-Down Stock
·3 min read

The agency is allowing Lilly's product to be used as a prophylaxis in people who have been exposed to the virus.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting